What You Should Know
Thatch, the healthcare benefits platform transitioning employers from traditional group coverage to consumer-directed health budgets, raised $108 million in new funding at a $1 billion valuation on September 15, 2026.The financing round was co-led by The General Partnership, Index Ventures, General Catalyst, and Andreessen Horowitz (a16z), with strategic participation from ADP Ventures, Paychex, Eli Lilly and Company, Scale Venture Partners, QuantumLight, SemperVirens,
Read More
Startups| Digital Health | | Health IT News, Analysis, Insights - HIT Consultant
Inspiren Secures $70M to Scale Physical AI Across Senior Living
What You Should Know
Senior living physical artificial intelligence pioneer Inspiren has raised $70M in Series C funding at a post-money valuation exceeding $500M.The financing round was led by NewView Capital, with broad syndicate participation from Insight Partners, Primary Venture Partners, Scale Venture Partners, Vintage Investment Partners, Lightbank, Avenir Growth Capital, Story Ventures, and Camber Creek.Brings Inspiren’s total capital raised to $225M—marking the largest fundraising
Read More
Verily Secures Strategic Investment from NVIDIA to Accelerate Precision Health AI Platform
What You Should Know
Verily Health Inc. has secured a strategic equity investment from NVIDIA, extending its fundraising momentum following its corporate restructuring and initial $300 million funding round in early 2026.CU Healthcare Innovation Fund II, LP committed an additional follow-on investment, joining a capitalization syndicate that includes Alphabet (as a minority stakeholder), Series X Capital, and UCHealth.Directly accelerates commercial deployment of the Verily Pre Platform, the
Read More
Forus Triples Raises $150M to Put AI Agents in Every Medical Practice
What You Should Know
Forus, the AI-powered network connecting physicians, retail and specialty pharmacies, commercial payers, and biopharma manufacturers, announced a $150M Series C financing round at a $3B valuation.The round triples the company’s valuation just months following its Series B round, lifting cumulative equity financing past $300M.Led by seed-stage backer Bain Capital Ventures, the insider round featured 100% reinvestment from existing institutional backers, including Thrive
Read More
PatientIQ Closes $30M to Scale EHR-Integrated Outcomes Intelligence and RWE
What You Should Know
Healthcare outcomes intelligence leader PatientIQ has raised $30M in Series C financing led by Chicago-based healthcare private equity firm Hughes & Company, with continued backing from Health Enterprise Partners and August Capital.Since completing its Series B round in 2022, PatientIQ has scaled its EHR-integrated footprint from 200 to more than 870 healthcare provider organizations, covering over 17 million patients and capturing more than 70 million patient
Read More
Ultrahuman Raises $70M to Build a Multimodal Human-Computer Interface for Health
What You Should Know
Bengaluru-based health intelligence company Ultrahuman announced a $70M financing round to evolve from a consumer wearable maker into an extensible human-computer interface (HCI) platform centered on the human body.The syndicate includes corporate heavyweights Qualcomm Ventures and Labcorp (via the Labcorp Venture Fund), alongside venture and growth investors Alpha Wave, Blume Ventures, Nexus Venture Partners, and Alteria Capital.Expands Pulsomics, an embedded opt-in
Read More
Thyme Care Secures Over $125M, Launches Thyme Companies to Scale Oncology Innovation
What You Should Know
Value-based oncology navigation and management leader Thyme Care announced a Series E financing round exceeding $125M, led by Morgan Health.Strategic and institutional syndication includes major national payers and healthcare venture firms: Humana, CVS Health Ventures, AlleyCorp, HealthQuest Capital, Foresite Capital, Concord Health Partners, Frist Cressey Ventures, Town Hall Ventures, and a16z Bio + Health.The company manages more than $7Bin annual oncology spend, with
Read More
Elucid Raises $55M to Expand Non-Invasive Cardiovascular Diagnostic Platform
What You Should Know
Boston-based cardiovascular medtech innovator Elucid closed an oversubscribed $55M Series D financing round, bringing its cumulative funding to approximately $185M.The round features participation from a new major, publicly traded medical device company—becoming Elucid’s fourth publicly traded strategic backer—alongside existing investors including IAG Capital Partners and Elevage Medical Technologies (a Patient Square Capital platform).Proceeds will accelerate the
Read More
N-Power Medicine Closes $32M to Expand Community Oncology Research
What You Should Know
Oncology drug development platform N-Power Medicine closed a $32M Series B financing round to scale its community oncology clinical research network and expand adoption of its Prospective External Control Arms (ProECA) technology.The financing features Labcorp Venture Fund as a new strategic investor, alongside continued participation from Merck Global Health Innovation Fund (Merck GHI), Innovatus Capital Partners, and a leading U.S.-based biotechnology investor.Solves a
Read More
Scan.com Secures $220M to Scale National Diagnostic Imaging API
What You Should Know
Diagnostic medical imaging network Scan.com has closed $220M in combined equity and debt financing, comprising a $90 million Series C equity round and $130M in debt facilities.The equity financing was led by Noteus Partners, with participation from Aviva, Concord Health Partners, YZR Capital, and Oxford Capital; debt facilities to support M&A and working capital were provided by VerisFi Capital and Atempo Growth.Follows a period of rapid growth where Scan.com doubled
Read More
